Tips about Lactoferrin and COVID-19 you need to know
Oct 09, 2021
Many high-income countries including Australia have been playing vaccine roulette with our public health. Lockdowns and personal restrictions have been applied while institutions wait for the vaccine effect to kick in. I’m not here to question the principle of immunization that prevents disease transmission and infection which in many areas of application is effective. BUT...The problem is that the majority narrative for vaccine safety has not adequately looked at complementary strategies like other treatments, strengthening the health system, non-pharmaceutical prevention, promotion of safe infection control practices and perhaps above all, a healthy lifestyle. This talk will look at another complementary strategy and is a follow-on from my OpEd paper and talk on the potential benefits of nicotine against COVID infection. A comment on this video suggested I should make a video on some outstanding University of Michigan research just published at the end of August 2021. I was curious and looked into this. WOW…important research and I want to bring you an overview of this and how you can take advantage of this yourselves. Despite vaccination there is a need for antiviral compounds that can (i) control local outbreaks, (ii) be used for home-based management and (iii) be used for immunocompromised people for whom vaccination is not suitable and this is required to (iv) slow the spread of variants of concern that may escape vaccine neutralisation. Repurposing already FDA-approved drugs is a good place to start to look for drugs that could be deployed as treatments for COVID-19. The U. Of Michigan research has developed a way to quantitatively screen actual SARS-CoV-2 infection in human cells and screen for drugs that show in vitro antiviral activity. The scientists screened 1425 drugs and found 17 that inhibited coronavirus infection. I’m focussing on the top #1 = Lactoferrin (bovine lactoferrin). They screened the 1425 FDA-approved compounds at 5 concentrations and looked for antiviral activity. The best performing drug was a nutraceutical called Lactoferrin. This is a protein found in colostrum and milk. It was able to block SARS-CoV-2 replication at the entry level. It was also found to be effective as a post-entry inhibitor. Lactoferrin is known to be: anti-microbial, antifungal, antiviral, and anti-parasitic. It possesses an anti-inflammatory, immunomodulatory,
and anti-cancer molecule. It is also a fundamental regulator of cellular iron homeostasis. Nutraceuticals like lactoferrin are natural compounds having potent antiviral activity, anti-inflammatory and anti-microbial activity and anti-cancer activity. It's a great candidate for combination therapies for COVID.
WATCH LIVE STREAM ON YOUTUBE:
Mirabelli, C., Wotring, J., Zhang, C., McCarty, S., Fursmidt, R., Pretto, C., Qiao, Y., Zhang, Y., Frum, T., Kadambi, N., Amin, A., O’Meara, T., Spence, J., Huang, J., Alysandratos, K., Kotton, D., Handelman, S., Wobus, C., Weatherwax, K., Mashour, G., O’Meara, M., Chinnaiyan, A. and Sexton, J., 2021. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proceedings of the National Academy of Sciences, 118(36), p.e2105815118.